255
Participants
Start Date
February 27, 2020
Primary Completion Date
February 14, 2023
Study Completion Date
February 14, 2023
NLY01
exenatide and polyethylene glycol (PEG)
Vehicle
Saline (Sodium Chloride)
NYU Langone Medical Center, The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, New York
Neurological Institute, Columbia University Medical Center, New York
University of Pennsylvania, Philadelphia
Georgetown University Hospital, Washington D.C.
University of Maryland, Neurology Ambulatory Center, Maryland Parkinson's Disease and Movement Disorder Center, Baltimore
Johns Hopkins University School of Medicine, Baltimore
University of Virginia, Charlottesville
Wake Forest Baptist Health Sciences, Winston-Salem
UNC CTRC, Chapel Hill
Raleigh Neurology, Raleigh
Duke University Medical Center, Durham
NeuroStudies, Decatur
Augusta University, Augusta
Charter Research, Winter Park
Mayo Clinic Florida, Jacksonville
University of Florida, Gainesville
Infinity Clinical Research, Hollywood
Visionary Investigators Network, Miami
University of Miami, Miami
Parkinson's Disease and Movement Disorder Center, Boca Raton
University of South Florida, Tampa
Nova Clinical Research, Bradenton
Renstar Medical Research, Ocala
University of Alabama at Birmingham, Birmingham
The Ohio State University Wexner Medical Center, Columbus
University of Toledo, Gardner-McMaster Parkinson Center, Toledo
University Hospitals Cleveland Medical Center, Cleveland
University of Michigan Hospital, Ann Arbor
Henry Ford West Bloomfield Hospital, West Bloomfield
Quest Research Institute, Farmington Hills
Froedtert Hospital, Milwaukee
University of Minnesota Delaware Clinical Research Unit, Minneapolis
Struthers Parkinson's Center, Golden Valley
Northwestern Medical Group Neurology Clinic, Chicago
Rush University Medical Center, Chicago
SIU Medicine, Springfield
University of Kansas Medical Center, Kansas City
University of Arkansas for Medical Sciences, Little Rock
The Movement Disorder Clinic of Oklahoma, Tulsa
Baylor College of Medicine, Houston
Rocky Mountain Movement Disorder Center, Englewood
University of Colorado, Denver
St. Joseph's Hospital and Medical Center - Barrow Neurological Institute, Phoenix
Movement Disorders Center, Scottsdale
Mayo Clinic Arizona, Mayo Clinic Scottsdale, Scottsdale
Banner Sun Health Research Institute, Sun City
Keck School of Medicine of USC/University of Southern California, Los Angeles
University of California, Los Angeles, Center for Neurotherapeutics, Los Angeles
SC3 Research, Pasadena
University of California, Irvine, Irvine
University of California, San Francisco, San Francisco
University of California Davis Health, Sacramento
Oregon Health and Science University, Portland
Booth Gardner Parkinson's Care Center, Kirkland
Institute for Neurodegenerative Disorders, New Haven
Massachusetts General Hospital Clinical Trials Pharmacy, Boston
Boston University Medical Center, Boston
Beth Israel Deaconess Medical Center, Boston
Neurology Specialists of Monmouth County, West Long Branch
Rhode Island Hospital, Providence
Toronto Western Hospital, Toronto
Lead Sponsor
Neuraly, Inc.
INDUSTRY